Molecular Rationale behind the Differential Substrate Specificity of Bacterial RND Multi-Drug Transporters

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Ramaswamy, Venkata Krishnan ^a   Vargiu, Attilio V ^a   Malloci, Giuliano ^a   Dreier, Jürg ^b   Ruggerone, Paolo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b BASILEA PHARMACEUTICA INTERNATIONAL LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACRB PROTEIN, E COLI; CARRIER PROTEIN; ESCHERICHIA COLI PROTEIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN; OUTER MEMBRANE PROTEIN; PROTEIN BINDING;

ANTIBIOTIC RESISTANCE; CELL DIVISION; DRUG DESIGN; ENZYME SPECIFICITY; ESCHERICHIA COLI; METABOLISM; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; PHYSIOLOGY; PROTEIN CONFORMATION;

BACTERIAL OUTER MEMBRANE PROTEINS; CELL DIVISION; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR DYNAMICS SIMULATION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY;

EID: 85027516263     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-08747-8     Document Type: Article

References (84)

1. World Health Organization. Antimicrobial resistance: Global report on surveillance. http://apps.who.int/iris/bitstream/10665/112642/1/9789241564748-eng.pdf (January 2016) (2014).
2. Nikaido, H. Prevention of drug access to bacterial targets: Permeability barriers and active efflux. Science 264, 382-388, doi: 10.1126/science.8153625 (1994).
3. Li, X.-Z., Plésiat, P., Nikaido, H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin. Microbiol. Rev. 28, 337-418, doi: 10.1128/CMR.00117-14 (2015).
4. Blair, J. M., et al. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc. Natl. Acad. Sci. USA 112, 3511-3516, doi: 10.1073/pnas.1419939112 (2015).
5. Poole, K. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56, 20-51, doi: 10.1093/jac/dki171 (2005).
6. Piddock, L. J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19, 382-402, doi: 10.1128/CMR.19.2.382-402.2006 (2006).
7. Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O., Piddock, L. J. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13, 42-51, doi: 10.1038/nrmicro3380 (2015).
8. Ruggerone, P., Murakami, S., M Pos, K., Vargiu, A. V. RND efflux pumps: Structural information translated into function and inhibition mechanisms. Curr. Top. Med. Chem. 13, 3079-3100, doi: 10.2174/15680266113136660220 (2013).
9. Misra, R., Bavro, V. N. Assembly and transport mechanism of tripartite drug efflux systems. Biochim. Biophys. Acta, Proteins Proteomics 1794, 817-825, doi: 10.1016/j.bbapap.2009.02.017 (2009).
10. Symmons, M. F., Bokma, E., Koronakis, E., Hughes, C., Koronakis, V. The assembled structure of a complete tripartite bacterial multidrug efflux pump. Proc. Natl. Acad. Sci. USA 106, 7173-7178, doi: 10.1073/pnas.0900693106 (2009).
11. Du, D., et al. Structure of the AcrAB-TolC multidrug efflux pump. Nature 509, 512-515, doi: 10.1038/nature13205 (2014).
12. Zgurskaya, H. I., Weeks, J. W., Ntreh, A. T., Nickels, L. M., Wolloscheck, D. Mechanism of coupling drug transport reactions located in two different membranes. Front. Microbiol. 6, 100, doi: 10.3389/fmicb.2015.00100 (2015).
13. Song, S., Kim, J.-S., Lee, K., Ha, N.-C. Molecular architecture of the bacterial tripartite multidrug efflux pump focusing on the adaptor bridging model. J. Microbiol. 53, 355-364, doi: 10.1007/s12275-015-5248-4 (2015).
14. Murakami, S., Nakashima, R., Yamashita, E., Matsumoto, T., Yamaguchi, A. Crystal structures of a multidrug transporter reveal a functionally rotating mechanism. Nature 443, 173-179, doi: 10.1038/nature05076 (2006).
15. Nakashima, R., Sakurai, K., Yamasaki, S., Nishino, K., Yamaguchi, A. Structures of the multidrug exporter AcrB reveal a proximal multisite drug-binding pocket. Nature 480, 565-569, doi: 10.1038/nature10641 (2011).
16. Eicher, T., et al. Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. Proc. Natl. Acad. Sci. USA 109, 5687-5692, doi: 10.1073/pnas.1114944109 (2012).
17. Nakashima, R., et al. Structural basis for the inhibition of bacterial multidrug exporters. Nature 500, 102-106, doi: 10.1038/nature12300 (2013).
18. Eicher, T., et al. Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB. Elife 3, e03145, doi: 10.7554/eLife.03145 (2014).
19. Symmons, M. F., Marshall, R. L., Bavro, V. N. Architecture and roles of periplasmic adaptor proteins in tripartite efflux assemblies. Front. Microbiol. 6, 513, doi: 10.3389/fmicb.2015.00513 (2015).
20. Seeger, M. A., et al. Structural asymmetry of AcrB trimer suggests a peristaltic pump mechanism. Science 313, 1295-1298, doi: 10.1126/science.1131542 (2006).
21. Pos, K. M. Drug transport mechanism of the AcrB efflux pump. Biochim. Biophys. Acta, Proteins Proteomics 1794, 782-793, doi: 10.1016/j.bbapap.2008.12.015 (2009).
22. Kobayashi, N., Tamura, N., van Veen, H. W., Yamaguchi, A., Murakami, S. β-Lactam selectivity of multidrug transporters AcrB and AcrD resides in the proximal binding pocket. J. Biol. Chem. 289, 10680-10690, doi: 10.1074/jbc.M114.547794 (2014).
23. Schuster, S., Vavra, M., Kern, W. V. Evidence of a substrate discriminating entrance channel in the lower porter domain of the multidrug resistance efflux pump AcrB. Antimicrob. Agents Chemother. 60, 4315-4323, doi: 10.1128/AAC.00314-16 (2016).
24. Iyer, R., Ferrari, A., Rijnbrand, R., Erwin, A. L. A fluorescent microplate assay quantifies bacterial efflux and demonstrates two distinct compound binding sites in AcrB. Antimicrob. Agents Chemother. 59, 2388-2397, doi: 10.1128/AAC.05112-14 (2015).
25. Elkins, C. A., Nikaido, H. Substrate specificity of the RND-type multidrug efflux pumps AcrB and AcrD of Escherichia coli is determined predominately by two large periplasmic loops. J. Bacteriol. 184, 6490-6498, doi: 10.1128/JB.184.23.6490-6499.2002 (2002).
26. Mao, W., et al. On the mechanism of substrate specificity by resistance nodulation division (RND) type multidrug resistance pumps: The large periplasmic loops of MexD from Pseudomonas aeruginosa are involved in substrate recognition. Mol. Microbiol. 46, 889-901, doi: 10.1046/j.1365-2958.2002.03223.x (2002).
27. Eda, S., Maseda, H., Nakae, T. An elegant means of self-protection in gram-negative bacteria by recognizing and extruding xenobiotics from the periplasmic space. J. Biol. Chem. 278, 2085-2088, doi: 10.1074/jbc.C200661200 (2003).
28. Schulz, R., Vargiu, A. V., Collu, F., Kleinekathöfer, U., Ruggerone, P. Functional rotation of the transporter AcrB: Insights into drug extrusion from simulations. PLoS Comput. Biol. 6, e1000806, doi: 10.1371/journal.pcbi.1000806 (2010).
29. Vargiu, A. V., et al. Effect of the F610A mutation on substrate extrusion in the AcrB transporter: Explanation and rationale by molecular dynamics simulations. J. Am. Chem. Soc. 133, 10704-10707, doi: 10.1021/ja202666x (2011).
30. Vargiu, A. V., Nikaido, H. Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations. Proc. Natl. Acad. Sci. USA 109, 20637-20642, doi: 10.1073/pnas.1218348109 (2012).
31. Collu, F., Vargiu, A. V., Dreier, J., Cascella, M., Ruggerone, P. Recognition of imipenem and meropenem by the RND-transporter MexB studied by computer simulations. J. Am. Chem. Soc. 134, 19146-19158, doi: 10.1021/ja307803m (2012).
32. Fischer, N., Kandt, C. Three ways in, one way out: Water dynamics in the trans membrane domains of the inner membrane translocase AcrB. Proteins: Struct., Funct., Bioinf. 79, 2871-2885, doi: 10.1002/prot.23122 (2011).
33. Fischer, N., Kandt, C. Porter domain opening and closing motions in the multi-drug efflux transporter AcrB. Biochim. Biophys. Acta Biomembr. 1828, 632-641, doi: 10.1016/j.bbamem.2012.10.016 (2013).
34. Ruggerone, P., Vargiu, A. V., Collu, F., Fischer, N., Kandt, C. Molecular dynamics computer simulations of multidrug RND efflux pumps. Comput. Struct. Biotechnol. J. 5, 1-11, doi: 10.5936/csbj.201302008 (2013).
35. Vargiu, A. V., Ruggerone, P., Opperman, T. J., Nguyen, S. T., Nikaido, H. Molecular mechanism of MBX2319 inhibition of Escherichia coli AcrB multidrug efflux pump and comparison with other inhibitors. Antimicrob. Agents Chemother. 58, 6224-6234, doi: 10.1128/AAC.03283-14 (2014).
36. Zuo, Z., Wang, B., Weng, J., Wang, W. Stepwise substrate translocation mechanism revealed by free energy calculations of doxorubicin in the multidrug transporter AcrB. Sci. Rep. 5, 13905, doi: 10.1038/srep13905 (2015).
37. Zuo, Z., Weng, J., Wang, W. Insights into the inhibitory mechanism of D13-9001 to the multidrug transporter AcrB through molecular dynamics simulations. J. Phys. Chem. B 120, 2145-2154, doi: 10.1021/acs.jpcb.5b11942 (2016).
38. Ramaswamy, V. K., Cacciotto, P., Malloci, G., Vargiu, A. V., Ruggerone, P. Computational modelling of efflux pumps and their inhibitors. Essays Biochem. 61, 141-156, doi: 10.1042/EBC20160065 (2017).
39. Litwin, S., Jores, R. In Theoretical and Experimental Insights into Immunology Vol. 66 (eds Alan S Perelson, Gérard Weisbuch) 279-287 (Springer, 1992).
40. Šali, A., Blundell, T. L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815, doi: 10.1006/jmbi.1993.1626 (1993).
41. Cha, H.-J., Müller, R. T., Pos, K. M. Switch-loop flexibility affects transport of large drugs by the promiscuous AcrB multidrug efflux transporter. Antimicrob. Agents Chemother. 58, 4767-4772, doi: 10.1128/AAC.02733-13 (2014).
42. Husain, F., Bikhchandani, M., Nikaido, H. Vestibules are part of the substrate path in the multidrug efflux transporter AcrB of Escherichia coli. J. Bacteriol. 193, 5847-5849, doi: 10.1128/JB.05759-11 (2011).
43. Ciulli, A., Williams, G., Smith, A. G., Blundell, T. L., Abell, C. Probing hot spots at protein-ligand binding sites: A fragment-based approach using biophysical methods. J. Med. Chem. 49, 4992-5000, doi: 10.1021/jm060490r (2006).
44. Sjuts, H., et al. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Proc. Natl. Acad. Sci. USA 113, 3509-3514, doi: 10.1073/pnas.1602472113 (2016).
45. Imai, T., et al. Functionality mapping on internal surfaces of multidrug transporter AcrB based on molecular theory of solvation: Implications for drug efflux pathway. J. Phys. Chem. B 115, 8288-8295, doi: 10.1021/jp2015758 (2011).
46. Yamaguchi, A., Nakashima, R., Sakurai, K. Structural basis of RND-type multidrug exporters. Front. Microbiol. 6, 327, doi: 10.3389/fmicb.2015.00327 (2015).
47. Zakrzewska, K., Lavery, R., Pullman, B. The solvation contribution to the binding energy of DNA with non-intercalating antibiotics. Nucleic Acids Res. 12, 6559-6574, doi: 10.1093/nar/12.16.6559 (1984).
48. Levy, Y., Onuchic, J. N., Wolynes, P. G. Fly-casting in protein-DNA binding: Frustration between protein folding and electrostatics facilitates target recognition. J. Am. Chem. Soc. 129, 738-739, doi: 10.1021/ja065531n (2007).
49. Neyfakh, A. A. Mystery of multidrug transporters: The answer can be simple. Mol. Microbiol. 44, 1123-1130, doi: 10.1046/j.1365-2958.2002.02965.x (2002).
50. Murakami, S. Multidrug efflux transporter, AcrB-the pumping mechanism. Curr. Opin. Struct. Biol. 18, 459-465, doi: 10.1016/j.sbi.2008.06.007 (2008).
51. Bohnert, J. A., et al. Site-directed mutagenesis reveals putative substrate binding residues in the Escherichia coli RND efflux pump AcrB. J. Bacteriol. 190, 8225-8229, doi: 10.1128/JB.00912-08 (2008).
52. The UniProt Consortium. UniProt: A hub for protein information. Nucleic Acids Res. 43, D204-D212, doi: 10.1093/nar/gku989 (2015).
53. Madden, T. In The NCBI Handbook [Internet] (eds McEntyre Jo, Ostell Jim) (National Center for Biotechnology Information, 2013).
54. Sievers, F., et al. Fast, scalable generation of high quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539, doi: 10.1038/msb.2011.75 (2011).
55. Shen, M.-y, Sali, A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 15, 2507-2524, doi: 10.1110/ps.062416606 (2006).
56. AMBER 14 (University of California, San Francisco, 2014).
57. Laskowski, R. A., MacArthur, M. W., Moss, D. S., Thornton, J. M. PROCHECK: A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283-291, doi: 10.1107/S0021889892009944 (1993).
58. Colovos, C., Yeates, T. Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci. 2, 1511-1519, doi: 10.1002/pro.5560020916 (1993).
59. Wiederstein, M., Sippl, M. J. ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res. 35, W407-W410, doi: 10.1093/nar/gkm290 (2007).
60. Eisenberg, D., Lüthy, R., Bowie, J. U. VERIFY3D: Assessment of protein models with three-dimensional profiles. Methods Enzymol. 277, 396-404, doi: 10.1016/S0076-6879(97λ7022-8 (1997).
61. Chen, V. B., et al. MolProbity: All-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12-21, doi: 10.1107/S0907444909042073 (2010).
62. Humphrey, W., Dalke, A., Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 14, 33-38, doi: 10.1016/0263-7855(96)00018-5 (1996).
63. The PyMOL Molecular Graphics System. Version 1.5.
64. Schulz, R., Vargiu, A. V., Ruggerone, P., Kleinekathöfer, U. Role of water during the extrusion of substrates by the efflux transporter AcrB. J. Phys. Chem. B 115, 8278-8287, doi: 10.1021/jp200996x (2011).
65. Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I., Lomize, A. L. OPM database and PPM web server: Resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370-D376, doi: 10.1093/nar/gkr703 (2012).
66. Jo, S., Kim, T., Iyer, V. G., Im, W. CHARMM GUI: A web based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859-1865, doi: 10.1002/jcc.20945 (2008).
67. Dickson, C. J., et al. Lipid14: The amber lipid force field. J. Chem. Theory Comput. 10, 865-879, doi: 10.1021/ct4010307 (2014).
68. Hopkins, C. W., Le Grand, S., Walker, R. C., Roitberg, A. E. Long-time-step molecular dynamics through hydrogen mass repartitioning. J. Chem. Theory Comput. 11, 1864-1874, doi: 10.1021/ct5010406 (2015).
69. Maier, J. A., et al. ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696-3713, doi: 10.1021/acs.jctc.5b00255 (2015).
70. Daidone, I., Amadei, A. Essential dynamics: Foundation and applications. Wiley Interdiscip. Rev. Comput. Mol. Sci. 2, 762-770, doi: 10.1002/wcms.1099 (2012).
71. Garciá, A. E. Large-amplitude nonlinear motions in proteins. Phys. Rev. Lett. 68, 2696-2699, doi: 10.1103/PhysRevLett.68.2696 (1992).
72. Ruiz-Carmona, S., et al. rDock: A fast, versatile and open source program for docking ligands to proteins and nucleic acids. PLoS Comput. Biol. 10, e1003571, doi: 10.1371/journal.pcbi.1003571 (2014).
73. Morley, S. D., Afshar, M. Validation of an empirical RNA-ligand scoring function for fast flexible docking using RiboDock®. J. Comput. Aided Mol. Des. 18, 189-208, doi: 10.1023/B:JCAM.0000035199.48747.1e (2004).
74. Gaillard, P., Carrupt, P.-A., Testa, B., Boudon, A. Molecular lipophilicity potential, a tool in 3D QSAR: Method and applications. J. Comput. Aided Mol. Des. 8, 83-96, doi: 10.1007/BF00119860 (1994).
75. Oberhauser, N., Nurisso, A., Carrupt, P.-A. MLP Tools: A PyMOL plugin for using the molecular lipophilicity potential in computer-aided drug design. J. Comput. Aided Mol. Des. 28, 587-596, doi: 10.1007/s10822-014-9744-0 (2014).
76. Baker, N. A., Sept, D., Joseph, S., Holst, M. J., McCammon, J. A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 98, 10037-10041, doi: 10.1073/pnas.181342398 (2001).
77. Dolinsky, T. J., Nielsen, J. E., McCammon, J. A., Baker, N. A. PDB2PQR: An automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32, W665-W667, doi: 10.1093/nar/gkh381 (2004).
78. Abraham, M. J., et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19-25, doi: 10.1016/j.softx.2015.06.001 (2015).
79. Kozakov, D., et al. The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat. Protoc. 10, 733-755, doi: 10.1038/nprot.2015.043 (2015).
80. Nishino, K., Yamaguchi, A. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183, 5803-5812, doi: 10.1128/JB.183.20.5803-5812.2001 (2001).
81. Sulavik, M. C., et al. Antibiotic Susceptibility Profiles of Escherichia coli Strains Lacking Multidrug Efflux Pump Genes. Antimicrob. Agents Chemother. 45, 1126-1136, doi: 10.1128/AAC.45.4.1126-1136.2001 (2001).
82. Nishino, K., Nikaido, E., Yamaguchi, A. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochim. Biophys. Acta, Proteins Proteomics 1794, 834-843, doi: 10.1016/j.bbapap.2009.02.002 (2009).
83. Rosenberg, E. Y., Ma, D., Nikaido, H. AcrD of Escherichia coli is an aminoglycoside efflux pump. J. Bacteriol. 182, 1754-1756, doi: 10.1128/JB.182.6.1754-1756.2000 (2000).
84. Aires, J. R., Nikaido, H. Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. Bacteriol. 187, 1923-1929, doi: 10.1128/JB.187.6.1923-1929.2005 (2005).